TG Therapeutics, Inc. (TGTX) NASDAQ

30.07

-0.29(-0.96%)

Updated at March 20 04:00PM

Currency In USD

Valuation

Market Cap4.3B
Enterprise Value4.48B
P/E Ratio9.61
PEG Ratio0.1
Price/Sales Ratio7.79
Price/Book Ratio6.63
Enterprise/Revenue8.09
Enterprise/EBITDA37.09

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin0.73
Operating Margin0.2

Management Effectiveness

Return On Assets0.42
Return On Equity1.01

Income Statement

Revenue616.29M
Revenue/Share4.31
Gross Profit515.33M
EBITDA134.36M
Net Income447.18M
Diluted EPS2.77

Balance Sheet

Total Cash141.97M
Total Cash/Share0.99
Total Debt260.73M
Total Debt/Equity0.4
Current Ratio4.1
Book Value Per Share4.53

Price History

52-Week Change-30.05
52-Week High46.48
52-Week Low25.28
Moving Average 50 Days29.56
Moving Average 200 Days32.33

Statistics

Average Volume2.05M
Shares Outstanding159.69M
% Held by Institutions71.05

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor4:225
Last Split DateApril 30, 2012